Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trial
| Autor: | de Gooijer, Cornedine J, van der Noort, Vincent, Stigt, Jos A, Baas, Paul, Biesma, Bonne, Cornelissen, Robin, van Walree, Nico, van Heemst, Robbert C, Soud, Magdolen Youssef-El, Groen, Harry J M, den Brekel, Agnes J Staal-van, Buikhuisen, Wieneke A, Bootsma, Gerben P, Dammeijer, Floris, van Tinteren, Harm, Lalezari, Ferry, Aerts, Joachim G, Burgers, Jacobus A * |
|---|---|
| Zdroj: | In The Lancet Respiratory Medicine June 2021 9(6):585-592 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|